Skip to content

Sugammadex and Brain Waves

The Effect of Sugammadex of EEG-derived Index Values

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01142648
Enrollment
30
Registered
2010-06-11
Start date
2009-04-30
Completion date
2010-03-31
Last updated
2010-06-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anaesthesia

Keywords

Electroencephalogram, Electromyogram, Entropy Index, Bispectral Index, Reversal of neuromuscular blockade

Brief summary

According to our experience, electroencephalogram-based indices of anaesthetic state show elevated numbers after administration of sugammadex (new reversal of neuromuscular blockade). This can be due to altered anaesthetic state, or some kind of artefact. In this study, the phenomenon is evaluated in detail.

Detailed description

Rocuronium-induced neuromuscular blockade is antagonized with sugammadex or neostigmine. BIS, Entropy and the biosignal collected from the Entropy strip are collected on computer. The behaviour of these parameters before, during and after reversal on neuromuscular blockade will be analyzed in detail.

Interventions

DRUGSugammadex

Sugammadex 200 mg iv, single dose, bolus.

Neostigmine 2.5 mg and glycopyrrolate 0,5 mg, iv, single dose, bolus, diluted in 2 ml volume with saline

Sponsors

Tampere University Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* females giving informed consent * age range 18-65 years * elective surgery: gynaecological * general anaesthesia * ASA classification 1 or 2

Exclusion criteria

* pregnancy * body mass index \> 30 * disease affecting CNS * overuse of alcohol * drug abuse * unability to understand, read or use Finnish language

Design outcomes

Primary

MeasureTime frame
The behaviour of depth of anaesthesia indexes (BIS,SE,RE)30 minutes

Secondary

MeasureTime frame
The behaviour of electroencephalography30 minutes

Countries

Finland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026